Risk factors, histopathology and diagnostic accuracy in posterior placenta accreta spectrum disorders: systematic review and meta-analysis.
MRI
outcome
placenta accreta spectrum
posterior placenta
prenatal diagnosis
ultrasound
Journal
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology
ISSN: 1469-0705
Titre abrégé: Ultrasound Obstet Gynecol
Pays: England
ID NLM: 9108340
Informations de publication
Date de publication:
06 2021
06 2021
Historique:
revised:
30
06
2020
received:
27
04
2020
accepted:
22
07
2020
pubmed:
26
8
2020
medline:
16
12
2021
entrez:
26
8
2020
Statut:
ppublish
Résumé
To elucidate the risk factors, histopathological correlations and diagnostic accuracy of prenatal imaging in pregnancies complicated by posterior placenta accreta spectrum (PAS) disorders. MEDLINE, EMBASE and CINAHL were searched for studies reporting on women with posterior PAS. Inclusion criteria were women with posterior PAS confirmed either at surgery or on histopathological analysis. The outcomes explored were risk factors for posterior PAS, histopathological correlation and the diagnostic accuracy of ultrasound and magnetic resonance imaging (MRI) in detecting posterior PAS. Random-effects meta-analysis of proportions was used to analyze the data. Twenty studies were included. Placenta previa was present in 92.8% (107/114; 17 studies) of pregnancies complicated by posterior PAS, while 76.1% (53/88; 11 studies) of women had had prior uterine surgery, mainly a Cesarean section (CS) or curettage and 82.5% (66/77; 10 studies) were multiparous. When considering histopathological analysis in women affected by posterior PAS, 77.5% (34/44; 11 studies) had placenta accreta, 19.5% (8/44; 11 studies) had placenta increta and 9.3% (2/44; 11 studies) had placenta percreta. Of the cases of posterior PAS disorder, 52.4% (31/63; 12 studies) were detected prenatally on ultrasound, while 46.7% (32/63; 12 studies) were diagnosed only at birth. When exploring the distribution of the classic ultrasound signs of PAS, placental lacunae were present in 39.0% (12/30; seven studies), loss of the clear zone in 41.1% (13/30; seven studies) and bladder-wall interruption in 16.6% (4/30; seven studies) of women, while none of the included cases showed hypervascularization at the bladder-wall interface. When assessing the role of MRI in detecting posterior PAS, 73.5% (26/32; 11 studies) of cases were detected on prenatal MRI, while 26.5% (6/32; 11 studies) were discovered only at the time of CS. Placenta previa, prior uterine surgery and multiparity represent the most commonly reported risk factors for posterior PAS. Ultrasound had a very low diagnostic accuracy in detecting these disorders prenatally. © 2020 International Society of Ultrasound in Obstetrics and Gynecology.
Types de publication
Journal Article
Meta-Analysis
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
903-909Informations de copyright
© 2020 International Society of Ultrasound in Obstetrics and Gynecology.
Références
Cali G, Forlani F, Lees C, Timor-Tritsch I, Palacios-Jaraquemada J, Dall'Asta A, Bhide A, Flacco ME, Manzoli L, Labate F, Perino A, Scambia G, D'Antonio F. Prenatal ultrasound staging system for placenta accreta spectrum disorders. Ultrasound Obstet Gynecol 2019; 53: 752-760.
Belfort MA. Placenta accreta. Am J Obstet Gynecol 2010; 203: 430-439.
Iacovelli A, Liberati M, Khalil A, Timor-Trisch I, Leombroni M, Buca D, Milani M, Flacco ME, Manzoli L, Fanfani F, Calì G, Familiari A, Scambia G, D'Antonio F. Risk factors for abnormally invasive placenta: a systematic review and meta-analysis. J Matern Fetal Neonatal Med 2020; 33: 471-481.
Silver RM, Fox KA, Barton JR, Abuhamad AZ, Simhan H, Huls CK, Belfort MA, Wright JD. Center of excellence for placenta accreta. Am J Obstet Gynecol 2015; 212: 561-568.
Buca D, Liberati M, Calì G, Forlani F, Caisutti C, Flacco ME, Manzoli L, Familiari A, Scambia G, D'Antonio F. Influence of prenatal diagnosis of abnormally invasive placenta on maternal outcome: systematic review and meta-analysis. Ultrasound Obstet Gynecol 2018; 52: 304-309.
Calì G, Timor-Trisch IE, Palacios-Jaraquemada J, Monteaugudo A, Forlani F, Minneci G, Foti F, Buca D, Familiari A, Scambia G, Liberati M, D'Antonio F. Changes in ultrasonography indicators of abnormally invasive placenta during pregnancy. Int J Gynaecol Obstet 2018; 140: 319-325.
Calí G, Timor-Tritsch IE, Forlani F, Palacios-Jaraquemada J, Monteagudo A, Agten AK, Flacco ME, Khalil A, Buca D, Manzoli L, Liberati M, D'Antonio F. Value of first-trimester ultrasound in prediction of third-trimester sonographic stage of placenta accreta spectrum disorder and surgical outcome. Ultrasound Obstet Gynecol 2020; 55: 450-459.
Familiari A, Liberati M, Lim P, Pagani G, Cali G, Buca D, Manzoli L, Flacco ME, Scambia G, D'Antonio F. Diagnostic accuracy of magnetic resonance imaging in detecting the severity of abnormal invasive placenta: a systematic review and meta-analysis. Acta Obstet Gynecol Scand 2018; 97: 507-520.
Pagani G, Cali G, Acharya G, Trisch IT, Palacios-Jaraquemada J, Familiari A, Buca D, Manzoli L, Flacco ME, Fanfani F, Liberati M, Scambia G, D'Antonio F. Diagnostic accuracy of ultrasound in detecting the severity of abnormally invasive placentation: a systematic review and meta-analysis. Acta Obstet Gynecol Scand 2018; 97: 25-37.
Finazzo F, D'Antonio F, Masselli G, Forlani F, Palacios-Jaraquemada J, Minneci G, Gambarini S, Timor-Tritsch I, Prefumo F, Buca D, Liberati M, Khalil A, Cali G. Interobserver agreement in MRI assessment of severity of placenta accreta spectrum disorders. Ultrasound Obstet Gynecol 2020; 55: 467-473.
D'Antonio F, Timor-Tritsch IE, Palacios-Jaraquemada J, Monteagudo A, Buca D, Forlani F, Minneci G, Foti F, Manzoli L, Liberati M, Acharya G, Calì G. First-trimester detection of abnormally invasive placenta in high-risk women: systematic review and meta-analysis. Ultrasound Obstet Gynecol 2018; 51: 176-183.
Palacios-Jaraquemada JM, D'Antonio F, Buca D, Fiorillo A, Larraza P. Systematic review on near miss cases of placenta accreta spectrum disorders: correlation with invasion topography, prenatal imaging, and surgical outcome. J Matern Fetal Neonatal Med 2020; 33: 3377-3384.
Cali G, Forlani F, Foti F, Minneci G, Manzoli L, Flacco ME, Buca D, Liberati M, Scambia G, D'Antonio F. Diagnostic accuracy of first-trimester ultrasound in detecting abnormally invasive placenta in high-risk women with placenta previa. Ultrasound Obstet Gynecol 2018; 52: 258-264.
Henderson LK, Craig JC, Willis NS, Tovey D, Webster AC. How to write a Cochrane systematic review. Nephrology (Carlton) 2010; 15: 617-624.
NHS Centre for Reviews and Dissemination. Systematic reviews: CRD's guidance for undertaking reviews in health care. University of York: York, UK, 2009. Available at: https://www.york.ac.uk/media/crd/Systematic_Reviews.pdf. [Accessed December 3, 2016].
Welch V, Petticrew M, Petkovic J, Moher D, Waters E, White H, Tuqwell P. Extending the PRISMA statement to equity-focused systematic reviews (PRISMA-E 2012): explanation and elaboration. J Clin Epidemiol 2016; 70: 68-89.
Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009; 151: 264-269.
Zorzela L, Loke YK, Ioannidis JP, Golder S, Santaguida P, Altman DG, Moher D, Vohra S; PRISMA harms group. PRISMA harms checklist: improving harms reporting in systematic reviews. BMJ 2016; 352: i157.
Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-2012.
Newcastle-Ottawa Scale for assessing the quality of nonrandomised studies in meta-analyses. Available at: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple graphical test. BMJ 1997; 315: 629-634.
Rutter CM, Gatsonis CA. A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations. Stat Med 2001; 20: 2865-2884.
Glas AS, Lijmer JG, Prins MH, Bonsel GJ, Bossuyt PM. The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol 2003; 56: 1129-1135.
Cochrane Handobook for Systematic Reviews of Diagnostic Test Accuracy, Chapter 10. http://srdta.cochra ne.org/handbook-dta-reviews.
Garofalo A, Pilloni E, Alemanno M, Garofalo G, Sciarrone A, Todros T, Viora E. Ultrasound accuracy in prenatal diagnosis of abnormal placentation of posterior placenta previa. Eur J Obstet Gynecol Reprod Biol 2019; 242: 86-91.
Morgan EA, Sidebottom A, Vacquier M, Wunderlich W, Loichinger M. The effect of placental location in cases of placenta accreta spectrum. Am J Obstet Gynecol 2019; 221: 357.e1-5.
Ishibashi H, Miyamoto M, Shinnmoto H, Murakami W, Soyama H, Nakatsuka M, Natsuyama T, Yoshida M, Takano M, Furuya K. Cervical varicosities may predict placenta accreta in posterior placenta previa: a magnetic resonance imaging study. Arch Gynecol Obstet 2017; 296: 731-736.
Lee HJ, Lee YJ, Ahn EH, Kim HC, Jung SH, Chang SW, Lee JY. Risk factors for massive postpartum bleeding in pregnancies in which incomplete placenta previa are located on the posterior uterine wall. Obstet Gynecol Sci 2017; 60: 520-526.
Budorick NE, Figueroa R, Vizcarra M, Shin J. Another look at ultrasound and magnetic resonance imaging for diagnosis of placenta accreta. J Matern Fetal Neonatal Med 2017; 30: 2422-2427.
Balcacer P, Pahade J, Spektor M, Staib L, Copel JA, McCarthy S. Magnetic Resonance Imaging and Sonography in The Diagnosis of Placental Invasion. J Ultrasound Med 2016; 35: 1445-1456.
Pilloni E, Alemanno MG, Gaglioti P, Sciarrone A, Garofalo A, Biolcati M, Botta G, Viora E, Todros T. Accuracy of ultrasound in antenatal diagnosis of placental attachment disorders. Ultrasound Obstet Gynecol 2016; 47: 302-307.
Gilboa Y, Spira M, Mazaki-Tovi S, Schiff E, Sivan E, Achiron R. A novel sonographic scoring system for antenatal risk assessment of obstetric complications in suspected morbidly adherent placenta. J Ultrasound Med 2015; 34: 561-567.
Kelekci S, Ekmekci E, Aydogmus S, Gencdal S. A comprehensive surgical procedure in conservative management of placenta accreta: a case series. Medicine (Baltimore) 2015; 94: 529.
Riteau A-S, Tassin M, Chambon G, Le Vaillant C, de Laveaucoupet J, Quéré M-P, Joubert M, Prevot S, Philippe H-J, Benachi A. Accuracy of ultrasonography and magnetic resonance imaging in the diagnosis of placenta accreta. PLoS One 2014; 9: e94866.
Zhou J, Li J, Yan P, Ye YH, Peng W, Wang S, Tong Wang X. Maternal plasma levels of cell-free β-hCG mRNA as a prenatal diagnostic indicator of placenta accreta. Placenta 2014; 35: 691-695.
Elhawary TM, Dabees NL, Youssef MA. Diagnostic value of ultrasonography and magnetic resonance imaging in pregnant women at risk for placenta accreta. J Matern Fetal Neonatal Med 2013; 26: 1443-1449.
Calì G, Giambanco L, Puccio G, Forlani F. Morbidly adherent placenta: evaluation of ultrasound diagnostic criteria and differentiation of placenta accreta from percreta. Ultrasound Obstet Gynecol 2013; 41: 406-412.
Wong HS, Cheung YK, Williams E. Antenatal ultrasound assessment of placental/myometrial involvement in morbidly adherent placenta. Aust NZ J Obstet Gynaecol 2012; 52: 67-72.
Palacios-Jaraquemada JM, Bruno CH, Martín E. MRI in the diagnosis and surgical management of abnormal placentation. Acta Obstet Gynecol Scand 2013; 92: 392-397.
Lim PS, Greenberg M, Edelson MI, Bell KA, Edmonds PR, Mackey AM. Utility of ultrasound and MRI In prenatal diagnosis of placenta accreta: a pilot study. AJR Am J Roentgenol 2011; 197: 1506-1513.
Masselli G, Brunelli R, Casciani E, Polettini E, Piccioni MG, Anceschi M, Gualdi G. Magnetic Resonance Imaging in the evaluation of placental adhesive disorders: correlation with color Doppler ultrasound. Eur Radiol 2008; 18: 1292-1299.
Dwyer BK, Belogolovkin V, Tran L, Rao A, Carroll I, Barth R, Chitkara U. Prenatal diagnosis of placenta accreta: sonography or magnetic resonance imaging? J Ultrasound Med 2008; 27: 1275-1281.
Warshak CR, Eskander R, Hull AD, Scioscia AL, Mattrey RF, Benirschke K, Resnik R. Accuracy of ultrasonography and magnetic resonance imaging in the diagnosis of placenta accreta. Obstet Gynecol 2006; 108: 573-581.
Chou MM, Ho ES, Lee YH. Prenatal diagnosis of placenta previa accreta by transabdominal color Doppler ultrasound. Ultrasound Obstet Gynecol 2000; 15: 28-35.